Prevention of anastrozole induced bone loss with monthly oral ibandronate: Final 5 year results from the ARIBON trial - Concepedia

Concepedia

Publication | Open Access

Prevention of anastrozole induced bone loss with monthly oral ibandronate: Final 5 year results from the ARIBON trial

DOI Full Paper Access

25

Citations

26

References

2012

Year

J. Lester, David Dodwell, Janet E. Brown, O.P. Purohit, Sandra A. Gutcher, Susan P. Ellis, Ruth Thorpe, Janet Horsman, Rob Coleman

Journal of bone oncology

Abstract

Monthly oral ibandronate provides an option to clinicians considering use of a bisphosphonate to prevent bone loss during aromatase inhibitor therapy.

References

	Year	Citations

Page 1